HHS Highlights Innovative Approaches Funded in Fiscal Year 2022 to Expand Care and Treatment for People with HIV

Content From: Health Resources and Services Administration, U.S. Dept. of Health and Human Services Published: November 18, 20223 min read



Cross-posted from HRSA Newsroom.

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), [on November 15, 2022], highlighted a series of innovative new approaches to expand care and treatment for people with HIV supported by the Ryan White HIV/AIDS Program in fiscal year 2022. Over the past year, HRSA awarded approximately $2.3 billion dollars to cities, counties, states, and local community-based organizations to provide life-saving care, treatment, and support services for over half a million people with HIV in the United States.

“Our Ryan White HIV/AIDS Program has transformed the lives of hundreds of thousands of people with HIV over the last three decades,” said HRSA Administrator Carole Johnson. “But we know there is more work to do to ensure people with HIV have access to the care and services they need. That’s why we are supporting innovative new approaches to reach underserved populations, address challenges to staying in care, and meet the needs of people with HIV across their lifespan.”

In fiscal year 2022, the Ryan White HIV/AIDS Program invested in new efforts involving pre-conception counseling for people with HIV, trauma-informed care, aging with HIV, housing for people with HIV who have been recently incarcerated, and supporting gender-affirming care for young LGBTQ people with HIV. To further promote the adoption of HIV care and treatment interventions to reduce HIV health disparities, the Ryan White HIV/AIDS Program also disseminated innovative and emerging strategies for grant recipients to address key needs of their patients, including housing, gender-affirming care, and substance use treatment. 

The most recent Ryan White HIV/AIDS Program data show a record-breaking 89.4 percent of clients were virally suppressed, which means they cannot sexually transmit the virus to an HIV-negative partner if they take their medication as prescribed. Three out of four people served by the Ryan White HIV/AIDS Program are from racial and ethnic minorities, and more than 60 percent are low income. 

Ryan White HIV/AIDS Program funding is provided to cities and counties most severely affected by HIV (Part A); states and territories (Part B); local community-based groups that provide ambulatory health services and support for people with HIV (Part C); local community-based groups that provide medical care for low-income women, infants, children and youth with HIV (Part D); and for HIV workforce education and training, oral health care, improving access to HIV care and health outcomes for minorities, and other innovative models of HIV care and treatment (Part F).

As part of the monkeypox outbreak response, the Biden-Harris Administration launched a national strategy to provide vaccines of MPx for individuals at higher risk of exposure. HRSA’s Ryan White HIV/AIDS Program and its grant recipients will continue to play a key role in ensuring people with HIV have the latest information on this outbreak. 

For a detailed breakdown of FY 2022 funding by Ryan White HIV/AIDS Program Part, visit https://ryanwhite.hrsa.gov/about/parts-and-initiatives/fy2022-awards.

To learn more about HRSA's Ryan White HIV/AIDS Program, visit ryanwhite.hrsa.gov.

For more information about HRSA's role in the Ending the HIV Epidemic in the U.S. (EHE) initiative, visit www.hrsa.gov/ending-HIV-epidemic.

To learn about the National HIV Strategy, visit: https://www.hiv.gov/federal-response/national-hiv-aids-strategy/national-hiv-aids-strategy-2022-2025.

For more information about HIV/AIDS prevention, testing, treatment, and research, visit HIV.gov.